AAIC 2025 Abstract
Evaluating Alzheimer's disease blood biomarkers in a real‐world primary care clinical population: The study design of SUNBIRD
Study in peopleBiomarkers
Abstract
Background: With the implementation of anti‐amyloid therapies to slow the progression of Alzheimer's disease (AD), early and accurate diagnosis is critical to identify individuals who may benefit from treatment.
